Genelux Corp (GNLX)
2.005
-0.20
(-8.86%)
USD |
NASDAQ |
Jun 28, 16:00
2.11
+0.10
(+5.24%)
After-Hours: 20:00
Genelux Profit Margin (Quarterly): -98.12K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -98.12K% |
December 31, 2023 | |
September 30, 2023 | |
June 30, 2023 |
Date | Value |
---|---|
March 31, 2023 | -6.10K% |
December 31, 2022 | -5.14K% |
September 30, 2022 | 44.63% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-98.12K%
Minimum
Mar 2024
44.63%
Maximum
Sep 2022
-27.33K%
Average
-5.62K%
Median
Profit Margin (Quarterly) Benchmarks
Verastem Inc | -- |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | -14.54K% |
IGC Pharma Inc | -978.0% |
NovaBay Pharmaceuticals Inc | -122.2% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -154.3% |
Return on Assets | -97.21% |
Return on Invested Capital | -151.1% |
Operating Margin (Quarterly) | -101.4K% |
Return on Net Operating Assets | -234.9% |